Market Tracker

08/31 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

30.99
Delayed Data
As of Aug 31
 +0.10 / +0.32%
Today’s Change
20.07
Today|||52-Week Range
37.88
+9.54%
Year-to-Date
These 3 Stocks Are Up Over 700% in the Last 5 Years
Aug 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close30.89
Today’s open30.92
Day’s range30.61 - 31.40
Volume191,075
Average volume (3 months)282,417
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+57.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio129.1
Price/Sales11.37
Price/Book8.29

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.22-0.73%
INSYINSYS Therapeutics I...-0.06-0.42%
SUPNSupernus Pharmaceuti...-0.49-2.24%
EBSEmergent BioSolution...-0.41-1.52%
Data as of 4:02pm ET, 08/31/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts